ADVFN Logo ADVFN
Donnée du Marché
Actualité
Outils
Donnée du Marché
Discover

Hot Features

Follow Feed

Rester connecter avec les traders et investisseurs dans notre communauté Follow Feed.

Flux des Options

Explorez des données complètes sur les options et utilisez les filtres avancés avec Options Flow.

Moniteur

Organisez et surveillez vos d'actions et actifs avec le Moniteur.
Se connecter Premium IconPremium Help Menu
CAC 40
7 695,78
0,83%
Dow Jones
39 308,00
-0,06%
DAX
18 450,48
0,38%
Brent Oil
87,055
-0,31%
Bitcoin
57 157,19
0,31%
Registration Strip Icon for monitor Surveillez plusieurs cotations en temps réel des principales bourses, telles que Euronext Paris, NASDAQ, NYSE, AMEX, Bovespa et plus encore.
S'inscrire
  1. Accueil
  2. Investir
  3. Actions
  4. Etats-Unis
  5. NASDAQ
  6. Petros Pharmaceuticals Inc (PTPI)

  7. Petros Pharmaceuticals Inc (PTPI) Actualités

PTPI

Petros Pharmaceuticals (PTPI)

Petros Pharmaceuticals Inc
De:
Trier par:
 Showing the most relevant articles for your search:NASDAQ:PTPI
DateHeureSourceTitreSymboleSociété
31/05/202423h07Edgar (US Regulatory)Form 10-K/A - Annual report [Section 13 and 15(d), not S-K Item 405]: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
21/05/202406h15Edgar (US Regulatory)Form EFFECT - Notice of EffectivenessNASDAQ:PTPIPetros Pharmaceuticals Inc
14/05/202413h00GlobeNewswire Inc.Lemonaid Health Now Offers Prescription ED Medication STENDRAⓇ Through Collaboration with Petros PharmaceuticalsNASDAQ:PTPIPetros Pharmaceuticals Inc
12/01/202422h32Edgar (US Regulatory)Form 8-K - Current reportNASDAQ:PTPIPetros Pharmaceuticals Inc
26/12/202323h07Edgar (US Regulatory)Form 4 - Statement of changes in beneficial ownership of securitiesNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202322h07Edgar (US Regulatory)Form ARS - Annual Report to Security HoldersNASDAQ:PTPIPetros Pharmaceuticals Inc
30/11/202322h05Edgar (US Regulatory)Form DEF 14A - Other definitive proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202323h11Edgar (US Regulatory)Form 10-Q - Quarterly report [Sections 13 or 15(d)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202323h00Edgar (US Regulatory)Form NT 10-Q - Notification of inability to timely file Form 10-Q or 10-QSBNASDAQ:PTPIPetros Pharmaceuticals Inc
19/09/202322h36Edgar (US Regulatory)Form 424B3 - Prospectus [Rule 424(b)(3)]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/09/202323h16Edgar (US Regulatory)Form S-3/A - Registration statement under Securities Act of 1933: [Amend]NASDAQ:PTPIPetros Pharmaceuticals Inc
15/08/202323h01Edgar (US Regulatory)Form PRE 14A - Other preliminary proxy statementsNASDAQ:PTPIPetros Pharmaceuticals Inc
11/08/202322h31Edgar (US Regulatory)Form S-3 - Registration statement under Securities Act of 1933NASDAQ:PTPIPetros Pharmaceuticals Inc
21/07/202322h30Edgar (US Regulatory)Form D - Notice of Exempt Offering of SecuritiesNASDAQ:PTPIPetros Pharmaceuticals Inc
29/04/202300h08Edgar (US Regulatory)Statement of Changes in Beneficial Ownership (4)NASDAQ:PTPIPetros Pharmaceuticals Inc
22/12/202223h04Edgar (US Regulatory)Securities Registration: Employee Benefit Plan (s-8)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202214h34Edgar (US Regulatory)Current Report Filing (8-k)NASDAQ:PTPIPetros Pharmaceuticals Inc
15/11/202213h03Edgar (US Regulatory)Amended Quarterly Report (10-q/a)NASDAQ:PTPIPetros Pharmaceuticals Inc
21/10/202212h03Edgar (US Regulatory)Notice of Effectiveness (effect)NASDAQ:PTPIPetros Pharmaceuticals Inc
14/10/202222h07Edgar (US Regulatory)Post-effective Amendment to Registration Statement (pos Am)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/10/202223h01Edgar (US Regulatory)Proxy Statement (definitive) (def 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
30/09/202222h46Edgar (US Regulatory)Proxy Statement - Notice of Shareholders Meeting (preliminary) (pre 14a)NASDAQ:PTPIPetros Pharmaceuticals Inc
12/08/202223h14Edgar (US Regulatory)Quarterly Report (10-q)NASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202217h39GlobeNewswire Inc.NOTICE TO DISREGARD - Henry Crown and CompanyNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202216h27GlobeNewswire Inc.Petros Pharmaceuticals Responds to Fraudulent Press ReleaseNASDAQ:PTPIPetros Pharmaceuticals Inc
28/07/202215h25GlobeNewswire Inc.Petros Pharmaceuticals to be Acquired by Henry Crown and Company for $3.25 per shareNASDAQ:PTPIPetros Pharmaceuticals Inc
19/07/202215h15GlobeNewswire Inc.Petros Pharmaceuticals Kicks Off Social Media Campaign with Celebrity Physician Dr. Drew PinskyNASDAQ:PTPIPetros Pharmaceuticals Inc
16/05/202223h00GlobeNewswire Inc.Petros Pharmaceuticals Reports First Quarter 2022 Financial Results and Provides Corporate UpdateNASDAQ:PTPIPetros Pharmaceuticals Inc
03/05/202215h23GlobeNewswire Inc.Petros Pharmaceuticals to Pursue 505(B)(2) Pathway for H-100, Company’s Novel Topical Investigational Treatment for Peyronie’s Disease Which Impacts More Than 1 in 10 Men in the USNASDAQ:PTPIPetros Pharmaceuticals Inc
28/04/202203h25GlobeNewswire Inc.Petros Pharmaceuticals to Present at the Planet MicroCap Showcase 2022NASDAQ:PTPIPetros Pharmaceuticals Inc
 Showing the most relevant articles for your search:NASDAQ:PTPI

Dernières Valeurs Consultées

NYSE
KO
Coca Cola
EU
DG
Vinci
EU
ML
Michelin
EU
AI
Air Liquide
FTSE
UKX
FTSE 100
EU
RNO
Renault
NASDAQ
GOOGL
Alphabet
EU
LR
Legrand
EU
ORA
Orange
NYSE
JPM
JP Morgan Chase
COIN
ETHUSD
Ethereum
EU
AF
Air FranceKLM
EU
MC
Lvmh Moet Hennessy Louis...
NYSE
MCD
McDonalds
EU
CS
Axa
Delayed Upgrade Clock
ADVFN Logo
InvestorsHub

France
Société
Entreprise
Popular
Obtenir l'application
App Store
Google Play

Assistance: support@advfn.fr

En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales

© 2024 ADVFN PLC - Tous droits réservés